Abstract

ObjectivesWe studied the frequency and risk factors for loss of long-term non-progressor (LTNP) and HIV controller (HIC) status among patients identified as such in 2005 in the French Hospital Database on HIV (FHDH-ANRS CO4).MethodsWe selected patients who were treatment-naïve and asymptomatic in 2005 (baseline). Those with ≥8 years of known HIV infection and a CD4 cell nadir ≥500/mm3 were classified as LTNP and those with ≥10 years of known HIV infection and 90% of plasma viral load (VL) values ≤500 copies/ml in the absence of cART as HIC. cART initiation without loss of status and death from non AIDS-defining causes were considered as competing events.ResultsAfter 5 years of follow-up, 33% (95%CI; 27–42) of 171 LTNP patients and 17% (95%CI; 10–30) of 72 HIC patients had lost their status. In multivariable analyses, loss of LTNP status was associated with lower baseline CD4 cell counts and CD4/CD8 ratios. Only VL was significantly associated with loss of HIC status after adjustment for the baseline CD4 cell count, the CD4/CD8 ratio, and concomitant LTNP status. The hazard ratio for loss of HIC status was 5.5 (95%CI, 1.5–20.1) for baseline VL 50–500 vs ≤50 cp/mL, after adjustment for the baseline CD4 cell count.ConclusionsOne-third of LTNP and one-fifth of HIC patients lost their status after 5 years of follow-up, raising questions as to the possible benefits and timing of ART initiation in these populations.

Highlights

  • Individuals who spontaneously control HIV infection provide a model of natural protection relevant to vaccine development and immune intervention

  • One-third of long-term non progressors (LTNP) and one-fifth of HIV controllers (HIC) patients lost their status after 5 years of follow-up, raising questions as to the possible benefits and timing of ART initiation in these populations

  • We examined the frequency and predictive factors for loss of LTNP and HIC status over time among patients identified in the French Hospital Database on HIV (FHDH_ANRS CO4) in 2005 [11]

Read more

Summary

Introduction

Individuals who spontaneously control HIV infection provide a model of natural protection relevant to vaccine development and immune intervention. Many definitions coexist [1], these patients are generally defined as either long-term non progressors (LTNP) or HIV controllers (HIC), depending on whether they are defined based on immunologic or virologic factors and on protection of AIDS-defining events in the absence of antiretroviral treatment. Few studies have focused on the long-term outcomes of such rare patients [2,3,4,5,6,7,8,9], who will become more difficult to identify as new treatment guidelines recommend treatment initiation as early as possible. The management of the individuals already identified with such status is an issue for both patients and caregivers [10]. We examined the frequency and predictive factors for loss of LTNP and HIC status over time among patients identified in the French Hospital Database on HIV (FHDH_ANRS CO4) in 2005 [11]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call